Teigelkamp S, Achsel T, Mundt C, Göthel S F, Cronshagen U, Lane W S, Marahiel M, Lührmann R
Institut für Molekularbiologie und Tumorforschung, Philipps-Universität Marburg, Germany.
RNA. 1998 Feb;4(2):127-41.
Cyclophilins (Cyps) catalyze the cis/trans isomerization of peptidyl-prolyl bonds, a rate-limiting step in protein folding. In some cases, cyclophilins have also been shown to form stable complexes with specific proteins in vivo and may thus also act as chaperone-like molecules. We have characterized the 20kD protein of the spliceosomal 25S [U4/U6.U5] tri-snRNP complex from HeLa cells and show that it is a novel human cyclophilin (denoted SnuCyp-20). Purified [U4/U6.U5] tri-snRNPs, but not U1, U2, or U5 snRNPs, exhibit peptidyl-prolyl cis/trans isomerase activity in vitro, which is cyclosporin A-sensitive, suggesting that SnuCyp-20 is an active isomerase. Consistent with its specific association with tri-snRNPs in vitro, immunofluorescence microscopy studies showed that SnuCyp-20 is predominantly located in the nucleus, where it colocalizes in situ with typical snRNP-containing structures referred to as nuclear speckles. As a first step toward the identification of possible targets of SnuCyp-20, we have investigated the interaction of SnuCyp-20 with other proteins of the tri-snRNP. Fractionation of RNA-free protein complexes dissociated from isolated tri-snRNPs by treatment with high salt revealed that SnuCyp-20 is part of a biochemically stable heteromer containing additionally the U4/U6-specific 60kD and 90kD proteins. By coimmunoprecipitation experiments performed with in vitro-translated proteins, we could further demonstrate a direct interaction between SnuCyp-20 and the 60kD protein, but failed to detect a protein complex containing the 90kD protein. The formation of a stable SnuCyp-20/60kD/90kD heteromer may thus require additional factors not present in our in vitro reconstitution system. We discuss possible roles of SnuCyp-20 in the assembly of [U4/U6.U5] tri-snRNPs and/or in conformational changes occurring during the splicing process.
亲环蛋白(Cyps)催化肽基 - 脯氨酰键的顺/反异构化,这是蛋白质折叠中的限速步骤。在某些情况下,亲环蛋白在体内也被证明能与特定蛋白质形成稳定复合物,因此也可能作为伴侣样分子发挥作用。我们已对来自HeLa细胞的剪接体25S [U4/U6.U5]三小核核糖核蛋白复合物的20kD蛋白进行了表征,并表明它是一种新型人类亲环蛋白(命名为SnuCyp - 20)。纯化的[U4/U6.U5]三小核核糖核蛋白,而不是U1、U2或U5小核核糖核蛋白,在体外表现出肽基 - 脯氨酰顺/反异构酶活性,该活性对环孢素A敏感,这表明SnuCyp - 20是一种活性异构酶。与其在体外与三小核核糖核蛋白的特异性结合一致,免疫荧光显微镜研究表明SnuCyp - 20主要位于细胞核中,在那里它与称为核斑点的典型含小核核糖核蛋白结构原位共定位。作为鉴定SnuCyp - 20可能靶点的第一步,我们研究了SnuCyp - 20与三小核核糖核蛋白其他蛋白质的相互作用。通过用高盐处理从分离的三小核核糖核蛋白中解离出的无RNA蛋白复合物进行分级分离,发现SnuCyp - 20是一种生化稳定异源二聚体的一部分,该异源二聚体还额外包含U4/U6特异性的60kD和90kD蛋白。通过对体外翻译的蛋白质进行共免疫沉淀实验,我们可以进一步证明SnuCyp - 20与60kD蛋白之间存在直接相互作用,但未能检测到含有90kD蛋白的蛋白复合物。因此,稳定的SnuCyp - 20/60kD/90kD异源二聚体的形成可能需要我们体外重组系统中不存在的其他因素。我们讨论了SnuCyp - 20在[U4/U6.U5]三小核核糖核蛋白组装和/或剪接过程中发生的构象变化中的可能作用。